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ABSTRACT
Background: To identify those characteristics of self-management interventions in patients with heart failure
(HF) that are effective in influencing health-related quality of life, mortality, and hospitalizations.
Methods and Results: Randomized trials on self-management interventions conducted between January
1985 and June 2013 were identified and individual patient data were requested for meta-analysis. Gener-
alized mixed effects models and Cox proportional hazard models including frailty terms were used to assess
the relation between characteristics of interventions and health-related outcomes. Twenty randomized trials
(5624 patients) were included. Longer intervention duration reduced mortality risk (hazard ratio 0.99, 95%
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confidence interval [CI] 0.97–0.999 per month increase in duration), risk of HF-related hospitalization (hazard
ratio 0.98, 95% CI 0.96–0.99), and HF-related hospitalization at 6 months (risk ratio 0.96, 95% CI 0.92–
0.995). Although results were not consistent across outcomes, interventions comprising standardized training
of interventionists, peer contact, log keeping, or goal-setting skills appeared less effective than interven-
tions without these characteristics.
Conclusion: No specific program characteristics were consistently associated with better effects of self-
management interventions, but longer duration seemed to improve the effect of self-management interventions
on several outcomes. Future research using factorial trial designs and process evaluations is needed to un-
derstand the working mechanism of specific program characteristics of self-management interventions in
HF patients. (J Cardiac Fail 2016;22:861–871)
Key Words: Heart failure, individual patient data meta-analysis, self-management.
Heart failure (HF) is a major health concern. Its preva-
lence is steadily increasing and presently more than 10% of
the people aged 85 years and older have been diagnosed with
HF.1 Patients suffering from HF are faced with lifestyle ad-
justment to prevent deterioration, daily medication intake, and
monitoring symptom changes.2 Interventions to support pa-
tients’ self-management behavior generally aim to equip
patients with skills to actively participate in the manage-
ment of their chronic condition, through stimulating symptom
monitoring and enhancing problem-solving and decision-
making skills for medical treatment management and healthy
lifestyle.3 Self-management interventions have received in-
creasing attention as they have been shown to affect a range
of outcomes, including all-cause hospitalization and HF-
related hospitalization.4,5 Despite favorable pooled effects,
several recent large randomized trials have shown inconclu-
sive results,6–8 raising new questions regarding the effectiveness
of those interventions.
A possible explanation for the ambiguous findings across
trials can be sought in the diversity of interventions being
evaluated. Self-management interventions vary widely in terms
of intensity, duration, content, and delivery.9 Analysis of mul-
tiple studies in a meta-analysis or meta-regression may provide
insight into the program characteristics that are associated with
better outcomes. This knowledge may contribute to the optimal
design of effective self-management interventions.
Previous meta-analyses have tried to identify essential
program characteristics by focusing on delivery of the
intervention to patients. Interventions using face-to-
face communication10 and a multidisciplinary team of
interventionists10,11 were found to be more effective than in-
terventions without these strategies. However, only a small
selection of program characteristics was analyzed, isolated
from other characteristics, thereby ignoring the possible impact
of other characteristics on the outcome.12
Although aggregated data of studies allow for estimating
global effects of program characteristics, using individual
patient data (IPD) enables a uniform imputation of missing
values and computation of treatment effects across studies.13
Analytic assumptions, such as uncertainties regarding program
characteristics, can be checked with principal investigators,
leading to a more reliable analysis.13 Our IPD meta-analysis
aims to identify program characteristics of self-management
interventions in patients with HF that affect HF-related quality
of life (HF-QoL), mortality, all-cause, and HF-related
hospitalization.
Material and Methods
Search Strategy and Study Selection
This IPD meta-analysis only included studies of self-
management interventions. All individual studies had received
approval from their local ethics committees, and this IPD meta-
analysis was exempted from the Medical Research Involving
Human Subjects Act of the Netherlands by the Medical Ethics
Research Committee of the University Medical Center Utrecht.
To identify randomized trials on self-management interven-
tions in patients with HF, the electronic databases of PubMed,
EMBASE, Cochrane Central Register of Controlled Trials,
PsycINFO, and CINAHL were searched from January 1985
through June 2013 (for search syntax in PubMed see
Supplementary Data Table S1) as well as reference lists from
systematic reviews.
Studies were selected by 2 independent researchers (NHJ
and HW). Discrepancies were resolved through consensus
with a third researcher (JCAT). Self-management interven-
tions were defined as interventions providing HF-related
information to patients and including at least 2 of the
following characteristics: (1) stimulation of sign/symptom
monitoring, (2) education on problem solving skills (ie,
self-treatment, stress/symptom management), and improve-
ment of (3) medical treatment adherence, (4) physical
activity, (5) dietary adherence, or (6) smoking cessation.
Studies were included in the IPD meta-analysis if they (1)
fulfilled the requirements of the definition of self-
management intervention, (2) had a randomized trial design,
(3) included patients with a confirmed diagnosis of HF, (4)
compared the self-management intervention with usual care
or another self-management intervention, (5) reported data
on 1 or more of the selected outcomes, (6) reported outcome
assessment for at least 6 months’ follow-up, and (7) were
reported in English, Dutch, French, German, Italian, Portu-
guese, or Spanish.
Data Collection
The principal investigators of selected studies were invited
to participate in this IPD meta-analysis and share their
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deidentified trial data. The complete list of all requested vari-
ables and details on collaboration with principal investigators
are reported in the published study protocol.14 Data from each
trial were checked on range, extreme values, internal con-
sistency, missing values, and consistency with published
reports.
Outcomes
To identify characteristics of effective self-management in-
terventions across different health outcomes, this study focused
on several main outcomes: HF-QoL at 6- and 12-month follow-
up (as measured with Heart Failure Symptom Scale,15 Kansas
City Cardiomyopathy Questionnaire,16 MacNew Heart Disease
Health-Related Quality of Life Instrument,17 or Minnesota
Living With Heart Failure Questionnaire18), mortality (time
to event, at 6 months, at 12 months), all-cause hospitaliza-
tion (time to first event, at 6 months, at 12 months), and HF-
related hospitalization (time to first event, at 6 months, at 12
months).
Program Characteristics
A selection of program characteristics was identified as po-
tential determinants of effective self-management interventions
based on literature on self-management and behavior change
and their presence across included studies:
1. Intensity: number of planned contacts between person
who delivered the intervention and patient, including
planned telephone contacts19
2. Duration: number of months that the intervention was
planned to be delivered to the patient19
3. Standardized training: type of training given to
person(s)who delivered the intervention to the patient
(standardized protocoled training/heterogeneous
nonprotocoled training)20
4. Multidisciplinary team: type of interventionist(s) deliv-
ering the intervention to the patient (multidisciplinary
team/single interventionist)10
5. Peer contact: contact with peer patients during the in-
tervention, including remote contact such as telephone
contact (yes/no)21,22
6. Keeping logs: stimulating patient to keep logs for moni-
toring symptoms (yes/no)23
7. Goal-setting skills: teaching patient goal-setting skills for
management of the condition or behavior change
(yes/no)21,22
8. Problem-solving skills: teaching patient problem-
solving skills for management of the condition (yes/no)21,22
9. Seeking support: teaching patient skills for seeking support
in social network, from caregivers, or from health care
professionals (yes/no).21
Information on program characteristics was extracted for
the intervention and control arms of all included studies, and
confirmed by the principal investigators.
Statistical Analysis
Original data from individual studies were merged to create
1 database. Missing values for baseline variables and out-
comes were imputed within studies only using multiple
imputation by chained equations (25 imputations)24; for an
overview of missing values per study, see Supplementary Data
(Table S2). The imputed datasets were used for the primary
analysis and results of imputed datasets were pooled using
Rubin’s rules.25
All analyses were performed according to the intention-
to-treat principle. Studies were analyzed using a 1-stage
approach (ie, simultaneously analyzing all observations while
accounting for clustering of observations and preserving ran-
domization within studies).26 The continuous outcomes (HF-
QoL at 6 and 12 months) were rescaled to ensure all scales
were in similar direction. Effects were quantified by stan-
dardized mean differences between intervention and control
arms and analyzed using linear mixed effects models. Binary
outcome data (mortality, all-cause, and HF-related hospital-
ization at 6- and 12-month follow-up) were analyzed with log-
binomial mixed effects models, which estimated risk ratios
(RRs). All mixed effects models included a random inter-
cept and random slope for the treatment effect to take
clustering within studies into account. For time-to-event end-
points, effects of self-management were quantified by
estimating hazard ratios (HRs) using Cox proportional-
hazard models, which included a frailty term for each study
to account for clustering within studies. This frailty term was
assumed to follow a normal distribution. The Cox propor-
tional hazard models were fitted using the frailty command
from the R package survival.
As an intermediary step in the analysis, we estimated the
main effects of the self-management interventions in general
(ie, without focusing on specific program characteristics). Main
effects have been reported elsewhere,27 but are presented to
enable a comparison of the effects of specific program char-
acteristics with the overall effects.
The primary analysis comprised the identification of
program characteristics of effective self-management inter-
ventions. Characteristics were evaluated 1-by-1 in separate
analyses. One trial had 2 intervention arms5; these were in-
cluded as separate interventions in the analysis. To identify
the effect of intensity and duration of interventions, the afore-
mentioned models were repeated with the covariate for
treatment (and random slope) being replaced by either in-
tensity or duration of the intervention. Hence, the effects of
intensity and duration were estimated irrespective of inter-
vention arm. A different approach was applied for analyzing
the binary program-specific characteristics. The studies were
grouped according to the presence or absence of a binary
program characteristic. Two regression models were then
applied in parallel to estimate the treatment effect of self-
management within both sets of studies. Differences between
the 2 estimated effects from the 2 sets of studies were tested
using a Q-test for heterogeneity.28 Modification of the effects
of program characteristics on clinical outcomes was
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considered statistically significant if this test yielded P < .05.
Only statistically significant findings from the primary anal-
ysis are presented to enable a direct comparison across the
different endpoints.
Several sensitivity analyses were performed to assess ro-
bustness of findings from the primary univariable analysis (see
Supplementary Data for details). All analyses were per-
formed in R for Windows, version 3.1.1 (R Development Core
Team. Released 2013. Vienna, Austria: R Foundation for Sta-
tistical Computing).
Results
Principal investigators of the 32 eligible studies were ap-
proached to participate in this IPD meta-analysis. Principal
investigators of 20 studies responded positively and shared
their deidentified trial data, representing 5624 patients in
total.6,7,29–47 The investigators of 5 studies could not be
contacted,8,48–51 4 principal investigators were not willing to
participate,52–55 and trial data of 2 studies were no longer
available.56–58
Baseline characteristics of HF patients are presented in
Table 1. Variables were well-balanced over the intervention
and control groups. The majority of patients were male (57%)
and the average age was 69.7 years (standard deviation 12.4).
The mean left-ventricular ejection fraction was 39.2% (stan-
dard deviation 18.2%) at baseline and most patients were in
New York Heart Association class II (39%) or III (37%).
Median time since diagnosis of HF was 1.6 years (interquartile
range 0.1–5.4).
Included Interventions
Included studies have been presented previously27 and are
described in Table 2. Studies were carried out between 1990
and 2007 in the United States,7,34,40–43 Netherlands,6,33,35,44
Sweden,29,37,46 Spain,30,31 Canada,47 Germany,39 Japan,38
Switzerland,36 and United Kingdom.32 Sample size ranged from
4236 to 1023 patients.6 Included interventions had an average
intensity of 11.5 planned contacts (range 1.6–32) and dura-
tion of 8.7 months (range 0.5–18). Table 3 presents program
characteristics per intervention. The majority of interven-
tions (15/21) used a standardized protocol to train
interventionists. Eight interventions (38%) involved a mul-
tidisciplinary team, 2 (10%) included contacts with peers, and
9 (43%) used logs for symptom monitoring. Patients were
taught goal-setting skills in 5 interventions (24%), problem-
solving skills in 6 (29%), and seeking support in 12
interventions (57%).
Primary Analysis of Program Characteristics
None of the program characteristics in self-management
interventions was effective for all endpoints considered.
However, several program characteristics showed an effect
on 1 or more endpoints (Table 4). Figure 1 presents a forest
plot for the effect on time to first all-cause hospitalization
across different program characteristics. The duration of the
interventions reduced risk on time to death, with a declin-
ing risk for each additional month of the intervention (hazard
ratio [HR] 0.99, 95% confidence interval [CI] 0.97–0.999).
A similar effect was observed for time to first HF-related
Table 1. Baseline Characteristics of Heart Failure Patients in Control and Self-Management Intervention Arm Included in the Individual
Patient Data Meta-Analysis
Characteristic Control (n = 2674) Intervention (n = 2950) Total (n = 5624)
Sex
Male 1505 (56.2) 1711 (58.0) 3126 (57.2)
Female 1169 (43.7) 1239 (42.0) 2408 (42.8)
Age—mean (SD) 69.9 (12.3) 69.6 (12.4) 69.7 (12.4)
Percentage LVEF—mean (SD) 39.7 (18.4) 38.7 (18.1) 39.2 (18.2)
NYHA class
I 190 (7.5) 168 (6.0) 358 (6.7)
II 951 (37.7) 1149 (41.0) 2100 (39.4)
III 899 (35.6) 1065 (38.0) 1964 (36.9)
IV 484 (19.2) 422 (15) 906 (17.0)
Years since diagnosis—median (IQR) 2.0 (0.1–6.0) 1.3 (0.1–5.2) 1.6 (0.1–5.4)
Level of education
Primary education or below 807 (42.3) 910 (39.4) 1717 (40.7)
Secondary education 711 (37.3) 939 (40.6) 1650 (39.1)
Higher education 388 (20.4) 461 (20.0) 849 (20.1)
Living status
Living with others 1064 (75.2) 1076 (73.2) 2140 (74.2)
Living alone 350 (24.8) 393 (26.8) 743 (25.8)
Clusters of comorbid conditions
Cardiovascular 1354 (59.7) 1310 (52.3) 2664 (55.8)
Endocrine 870 (36.2) 932 (34.6) 1802 (35.4)
Neurological/psychiatric 343 (17.8) 389 (17.5) 732 (17.6)
Respiratory 506 (27.0) 558 (25.7) 1664 (26.3)
Renal/hepatic/gastrointestinal 303 (24.7) 377 (24.7) 680 (24.7)
Musculoskeletal 76 (11.7) 147 (14.1) 223 (13.2)
IQR, interquartile range; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; SD, standard deviation.
Values are n (%), mean (SD), or median (interquartile range).
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Table 2. Description of Trials on Self-Management in Heart Failure Patients Included in the Individual Patient Data Meta-Analysis
Study Country
Sample
Size
Start
Recruitment Setting Control Group Intervention Group
Duration
(Mo)*
Agren
201229
Sweden 155 2005 Clinic/hospital
or home
Usual care (standard care in
hospital and outpatient
education and support)
3 individual sessions for patient and
partner by nurse
3
Aldamiz
200730
Spain 279 2001 Clinic/hospital
and home
Usual care (follow-up in primary
health care)
4 home visits by nurse/physician 0.5
Atienza
200431
Spain 338 1999 Clinic/hospital Usual care (discharge planning
according to protocol)
1 individual session prior to
discharge by nurse, 1 visit to
physician, 3-monthly follow-up
visits and tele-monitoring
12
Blue
200132
United
Kingdom
165 1997 Clinic/hospital
and home
Usual care (follow-up by
admitting physician and in
primary health care)
Home visits by nurse, follow-up
telephone calls with intensity
based on patient’s need
12
Bruggink
200733
Netherlands 240 2000 Clinic/hospital Usual care (including optimal
application of medical therapy)
2 individual sessions by nurse/
physician, 1 telephone call,
follow-up 6 visits
12
DeWalt
20127
United
States
605 2007 Clinic/hospital Enhanced usual care (1 initial
session on self-management
and educational manual)
1 individual session by trained
health educator, follow-up
multiple telephone calls
12
Heisler
201334
United
States
266 2007 Clinic/hospital
and home
Enhanced usual care (1 group
session on self-management
and educational materials)
1 group session by lay peer tutor,
weekly telephone contact with
matched peer, follow-up 3
optional group sessions
6
Jaarsma
199935
Netherlands 179 1994 Clinic/hospital
and home
Usual care (possibly including
written/oral information about
medication and lifestyle)
1 home visit and 1 telephone call
after discharge by nurse
0.5
Jaarsma
20086
Netherlands 1023 2002 Clinic/hospital Usual care (standard management
by cardiologist)
(A) 2 individual session by
cardiologist, 9 visits to nurse,
possibility to contact nurse
(B) 2 individual sessions by
cardiologist, 18 visits to nurse, 2
home visits, 2 multidisciplinary
sessions, follow-up telephone
contact by nurse
18
Leventhal
201136
Switzerland 42 2003 Clinic/hospital
and Home
Enhanced usual care (lifestyle
recommendations and
educational booklet)
1 home visit by nurse, educational
booklet, 17 follow-up telephone
calls
12
Martensson
200537
Sweden 153 1999 Home
(recruited
general
practice)
Usual care (follow-up in
multidisciplinary primary
health care)
1 individual session by nurse,
follow-up educational CD-ROM
and telephone contact
12
Otsu
201138
Japan 102 2007 Clinic/hospital Usual care (follow-up at a medical
facility)
6 individual sessions by nurse 6
Peters-
Klimm
201039
Germany 197 2006 Home
(recruited
general
practice)
Usual care (follow-up in primary
health care)
1 individual session by nurse/
physician, 3 follow-up home
visits and telephone calls
12
Rich
199540
United
States
282 1990 Clinic/hospital
and home
Usual care (follow-up by primary
physician)
Daily visits by multidisciplinary
professionals during
hospitalization, follow-up home
visits and telephone calls by
nurse at decreasing intensity
3
Riegel
200241
United
States
358 1998 Telephonic
case
management
Usual care (not standardized,
possibly including education on
heart failure management)
Telephone calls by nurse at
decreasing intensity
6
Riegel
200642
United
States
135 2002 Telephonic
case
management
Usual care (not standardized,
possibly including education on
heart failure management)
Telephone calls by nurse at
decreasing intensity
6
Sisk 200643 United
States
406 1999 Clinic/hospital Usual care (including federal
guidelines on heart failure)
1 individual session by nurse,
follow-up telephone calls
12
Smeulders
200944,45
Netherlands 317 2004 Clinic/hospital Usual care (including regular
check-ups with cardiologist
and/or nurse specialist in
outpatient clinic)
6 group sessions by lay peer tutor
and nurse, booklet, follow-up
telephone contact with
coparticipants
1.5
Stromberg
200346
Sweden 106 1997 Clinic/hospital Usual care (follow-up in primary
health care)
1 clinic visit shortly after discharge
by nurse, individualized follow-
up (face-to-face and/or
telephone)
12
Tsuyuki
200447
Canada 276 1999 Clinic/hospital Usual care (including general
brochure on heart disease)
1 individual session by pharmacist,
7 follow-up telephone calls by
nurse
6
*Duration of the self-management intervention evaluated in the study.
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hospitalization (HR 0.98, 95% CI 0.96–0.99) and HF-
related hospitalization at 6-month follow-up (RR 0.96, 95%
CI 0.92–0.995).
Interventions with standardized training of intervention-
ists showed no treatment effects in contrast to favorable effects
for interventions with heterogeneous training on time to first
all-cause hospitalization (interaction P = .001), all-cause hos-
pitalization at 6 months (interaction P = .009), at 12 months
(interaction P = .014), and time to first HF-related hospital-
ization (interaction P = .022). Interventions with a
multidisciplinary team showed no treatment effect on time
to first HF-related hospitalization, whereas the interven-
tions delivered by 1 person reduced the risk (interaction
P = .045). The 1 intervention comprising peer contact in the
analysis of mortality34 showed an increased risk on time to
death (HR 2.01, 95% CI 1.15–3.53) and mortality at 6 months
(RR 1.88, 95% CI 0.89–3.96), whereas the interventions
without peer contact reduced risk on time to death (HR 0.86,
95% CI 0.75–0.99, interaction P = .004) and mortality at 6
months (RR 0.79, 95% CI 0.63–0.97, interaction P = .028).
Interventions including log keeping showed no effects, whereas
interventions without logs showed favorable effects on time
to first all-cause hospitalization (interaction P ≤ .001), all-
cause hospitalization at 12 months (interaction P = .035), and
time to first HF-related hospitalization (interaction P = .001).
Interventions including goal-setting skills showed a trend
toward increased risk compared with risk reductions for in-
terventions without goal-setting skills on time to first all-
cause hospitalization (interaction P = .023), all-cause
hospitalization at 12 months (interaction P = .006), and
HF-related hospitalization at 12 months (interaction
P = .029).
Sensitivity Analysis
Observational analysis of the data in a multivariable model
confirmed the direction of effects, except for the effects of
standardized training (HR 0.55, 95% CI 0.29–1.08) and mul-
tidisciplinary teams (HR 0.91, 95% CI 0.64–1.29) on time
to HF-related hospitalization, now both appearing advanta-
geous (see Supplementary Data Table S3). The sensitivity
analyses, consisting of a complete-case analysis, repeating
the analyses by excluding the largest trial,6 and pooling the
published main effects of studies without individual patient
data available (see Supplementary Data Table S4) yielded
similar findings compared to the primary analysis.
Two post hoc sensitivity analyses were performed to check
for possible confounding by a time effect (ie, a possible de-
crease of treatment effects over time because of improvements
in usual care). One post hoc analysis included only older
studies (recruitment through 2000, N = 10), whereas the second
analysis included only recent studies (recruitment after 2000,
N = 10). Although effect sizes were more pronounced in the
subset of older studies, the direction of the effects of program
characteristics remained similar to the primary analysis (see
Supplementary Data Table S5).
Discussion
This IPD meta-analysis contributes to the discussion on the
optimal design of self-management interventions for pa-
tients with HF. Even analyzing 20 trials representing 5624
patients, we could not identify program characteristics that
showed a consistent pattern in modifying the effects of self-
management interventions across all outcomes considered.
Table 3. Program Characteristics of the Different Self-Management Interventions in Patients With Heart Failure Included in the Individual
Patient Data Meta-Analysis
Study
Year of
Recruitment
Standardized
Training
Multidisciplinary
Team
Peer
Contact
Keeping
Logs
Goal-Setting
Skills
Problem-Solving
Skills
Seeking
Support
Rich 199540 1990 X X X
Jaarsma 199935 1994 X
Blue 200132 1997 X X
Stromberg 200346 1997 X X
Riegel 200241 1998 X X
Sisk 200643 1999 X
Atienza 200431 1999 X
Tsuyuki 200447 1999 X X
Martensson 200537 1999 X
Bruggink 200733 2000 X X
Aldamiz 200730 2001 X
Jaarsma 2008a6,* 2002 X X X
Jaarsma 2008b6,* 2002 X X X X
Riegel 200642 2002 X X X
Leventhal 201136 2003 X X X X X
Smeulders 200944,45 2004 X X X X X X
Agren 201229 2005 X X X
Peters-Klimm 201039 2006 X X X X X
DeWalt 20127 2007 X X X
Heisler 201334 2007 X X X X
Otsu 201138 2007 X X X
*Study comprised 2 different intervention arms.
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However, longer duration of self-management interventions
reduced the risk on mortality and HF-related hospitaliza-
tion with 1–4% for each increasing month of the intervention.
Unfavorable associations were observed for standardized train-
ing of interventionists, log keeping, goal-setting, and peer
contact, but only on specific outcomes.
Meta-analyses of similar interventions have shown that the
use of multidisciplinary teams10,11 and face-to-face contact10
improved outcomes in patients with HF. Our primary anal-
ysis suggested only that a longer duration of self-management
interventions was more effective. It is likely that sustained
contact over time with a health care professional who helps
identify signs and symptoms of decompensation may support
the patient’s self-management. A similar finding was re-
ported by a meta-analysis of HF disease management
programs, which found an association between longer follow-
up of programs and reduced risk of mortality.59
In contrast to the previous meta-analyses,10,11 we found a
less favorable effect of multidisciplinary teams compared with
a single interventionist on time to first HF-related hospital-
ization. This effect disappeared after adjustment for other
program characteristics, suggesting a correlation with the
Table 4. Effects of Self-Management Interventions and Characteristics in Patients With HF Included in the Individual Patient
Data Meta-Analysis
Outcome
N
Studies
N
Patients Analysis
Effect
Measure Effect (95% CI)
P Value for
Heterogeneity
HF-related quality of life
6 mo follow-up 10 3419 Intervention effect SMD 0.13 (0.00–0.26) NA*
No significant characteristic
12 mo follow-up 11 3356 Intervention effect SMD 0.15 (0.00–0.30) NA
No significant characteristic
Mortality
Time to event 14 4312 Intervention effect HR 0.91 (0.79–1.04) NA
14 4312 Duration (per mo) 0.99 (0.97–0.999) .045
1 266 Peer contact 2.01 (1.15–3.53) .004
13 4046 No peer contact 0.86 (0.75–0.99)
6 mo follow-up 17 4985 Intervention effect RR 0.83 (0.66–1.05) NA
17 4985 Intensity (per contact) 0.97 (0.94–0.99) .007
1 266 Peer contact 1.88 (0.89–3.96) .028
16 4719 No peer contact 0.79 (0.63–0.97)
12 mo follow-up 14 4204 Intervention effect RR 0.86 (0.72–1.03) NA
No significant characteristic
All-cause hospitalization
Time to first event 12 3833 Intervention effect HR 0.93 (0.85–1.03) NA
9 2976 Standardized training 1.01 (0.91–1.13) .001
3 857 Heterogeneous training 0.70 (0.57–0.85)
5 2186 Keeping logs 1.11 (0.97–1.26) <.001
7 1647 No logs 0.78 (0.68–0.90)
2 644 Goal-setting skills 1.26 (0.96–1.66) .023
10 3186 No goal-setting skills 0.90 (0.81–0.99)
6 mo follow-up 14 4329 Intervention effect RR 0.92 (0.83–1.01) NA
10 3293 Standardized training 0.98 (0.89–1.08) .009
4 1036 Heterogeneous training 0.72 (0.58–0.89)
12 mo follow-up 13 4266 Intervention effect RR 0.95 (0.87–1.04) NA
9 3124 Standardized training 1.01 (0.92–1.12) .014
4 1139 Heterogeneous training 0.80 (0.69–0.94)
6 2389 Keeping logs 1.06 (0.93–1.20) .035
7 1874 No logs 0.87 (0.78–0.99)
4 1161 Goal-setting skills 1.17 (0.98–1.39) .006
9 3102 No goal-setting skills 0.89 (0.81–0.97)
HF-related hospitalization
Time to first event 10 3461 Intervention effect HR 0.80 (0.69–0.92) NA
10 3461 Duration (per mo) 0.98 (0.96–0.99) .002
7 2604 Standardized training 0.88 (0.75–1.04) .022
3 857 Heterogeneous training 0.61 (0.46–0.80)
3 1202 Multidisciplinary team 1.01 (0.80–1.28) .045
8 2598 Single interventionist 0.75 (0.64–0.88)
5 2186 Keeping logs 0.99 (0.82–1.20) .001
5 1275 No logs 0.61 (0.49–0.76)
6 mo follow-up 12 3741 Intervention effect RR 0.81 (0.66–0.99) NA
12 3741 Duration (per mo) 0.96 (0.92–0.995) .046
12 mo follow-up 11 3503 Intervention effect RR 0.82 (0.64–1.05) NA
3 844 Goal-setting skills 1.16 (0.84–1.61) .029
8 2659 No goal-setting skills 0.72 (0.55–0.95)
CI, confidence interval; HR, hazard ratio; NA, not available; RR, risk ratio; SMD, standardized mean difference.
Results are only presented if program characteristic showed an effect with P < .05 in the primary analysis. Boldface effect values are main effects of the
self-management interventions.
*Not applicable for main effects because reported P values indicate test for heterogeneity for specific program characteristic.
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presence of other characteristics. Because this effect disap-
pears, we do not believe our study contradicts the favorable
association reported by previous meta-analyses. The other ben-
eficial characteristic revealed by the prior meta-analysis, face-
to-face contact,10 could not be analyzed in our study because
it was known a priori that nearly all eligible interventions used
face-to-face contact. Overall, the self-management interven-
tions elicited favorable main effects on HF-QoL and HF-
related hospitalization. These effects could not be attributed
to any of the binary characteristics considered in our study.
The face-to-face contact present in nearly all intervention arms
might be a critical characteristic in explaining the favorable
effects of self-management interventions; this possibility de-
serves attention in future research.
From earlier work on social cognitive theory21,22 and meta-
regressions on effective behavior change techniques,20,23 we
assumed that standardized training of interventionists, keeping
logs for symptom-monitoring, goal-setting, and contact with
peers would positively influence the effect of self-management
interventions. However, our findings were counterintuitive and
showed that self-management interventions comprising those
characteristics resulted in less favorable outcomes than in-
terventions without those characteristics. It may be that studies
had commonalities on methodological aspects or on other
Fig. 1. Forest plot of effects of self-management interventions on time to first all-cause hospitalization with subgroup effects for program
characteristics. CI, confidence interval; HR, hazard ratio.
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characteristics that confounded our results60 (ie, additional
[medical] care provided along with the self-management
intervention). Inspection of other study characteristics and ag-
gregate baseline variables in tables61 revealed that there was
a tendency for the self-management program characteristics
to be particularly present in more recently conducted studies.
We hypothesized that treatment effects may have decreased
over time, because usual care has evolved because of in-
sights from research (ie, new treatments, more comprehensive
care protocols). Although the post hoc sensitivity analyses did
not confirm this hypothesis, differences in usual care given
to control patients or additional care given in the interven-
tion arms might still be confounding factors for the observed
effects. The information on usual care was limited and we
could not appropriately adjust for the wide diversity in usual
care in our analysis.
Without a clear explanation for the unfavorable effects, it
would be unjustified to recommend that self-management in-
terventions should not comprise specific program
characteristics. The large number of program characteris-
tics analyzed increases the chance of false-positive findings
and any observed effect therefore should be considered ex-
plorative rather than confirmative.61 Considering the complex
nature of self-management interventions, we might even ques-
tion the extent that researchers should look at isolated program
characteristics of complex self-management interventions in
a meta-regression analysis, because the interventions were de-
signed as a cohesive compilation instead of separate
characteristics.12 Our findings support the notion that effec-
tiveness of self-management interventions may not be
attributable to specific program characteristics, but rather that
certain types of interventions show a pattern of effects that
is dependent on the context in which the intervention is
delivered.62
From this perspective, this IPD meta-analysis should be
considered the first large effort toward identifying charac-
teristics of effective self-management interventions in patients
with HF. It applied a careful data collection and analysis, and
the causal nature of effect modifiers was addressed by check-
ing the primary findings on confounding factors. Nevertheless,
several limitations are worth discussing. First, despite the in-
clusion of 20 studies and data on 5624 patients, the number
of studies was too restricted for multivariable analysis using
mixed effects models, limiting causal interpretation of our find-
ings. Second, the use of meta-regression techniques required
a categorization of program-specific features. This may have
left room for interpretation of categories and may have created
large, still heterogeneous sets of studies being grouped to-
gether (ie, goal-setting in 1 study may have differed from that
in another study). Underreporting of intervention details pre-
vented us from creating detailed categories following existing
taxonomies like the behavior change technique taxonomy,63
which deserves attention by future trials. Finally, fidelity to
study protocols and adherence to interventions by patients was
unknown in a majority of included studies. Process evalua-
tions of behavioral interventions such as self-management
interventions have shown that fidelity to study protocols is
often compromised64,65; consequently, patients in the inter-
vention groups might have actually received different program
characteristics than assumed. The unavailability of these data
prevented assessment of the impact of treatment compli-
ance on the outcomes.66 This IPD meta-analysis highlights
the need for incorporating the complexity of this type of in-
tervention in the study design (eg, through carefully defining
intervention components, planning feasibility studies, and
process evaluations of intervention delivery alongside trials).
This may contribute to a thorough understanding of how the
intervention exerts its effects.
Conclusions
Despite the large numbers of patients included in this IPD
meta-analysis, no specific program characteristics could be
identified that were clearly associated with better outcomes
of self-management interventions. There were indications that
a longer duration positively modified the effects of self-
management interventions on several outcomes, supporting
sustained contact over time between health care profession-
als and patients with HF. Advances in usual care for patients
with HF over time may have confounded the effects ob-
served. Future research using factorial trial designs and process
evaluations is needed to assess adherence to self-management
interventions and understand the mechanism whereby self-
management interventions enhance clinical outcomes in
patients with HF.
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